UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): ~~June~~October 308, 2025

Bespoke Extracts, Inc.

(Exact name of registrant as specified in its charter)

Nevada		000-52759		20-4743354
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

12001 E.33^rd Ave Unit O

Aurora, CO 80010

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code (720-949-1143)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act: None.

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 21.0201 ~~Results~~Entry ofinto ~~Operations~~a ~~and~~Material ~~Financial~~Definitive ~~Condition~~Agreement.

On ~~June~~October 308, 2025, Bespoke Extracts, Inc.. (the “Company”) entered into an Amendment to Senior Note (the “Amendment”) with Infinity Management, LLC (the ~~issued~~“Holder”) to amend the Senior Note dated September 26, 2023, with a ~~press~~principal ~~release~~amount ~~announcing~~of ~~its~~$849,500.00 ~~financial~~(the “Note”). ~~results~~The ~~and~~Amendment ~~business~~modifies ~~highlights~~the ~~for~~Maturity Date of the ~~quarter~~Note ~~ended~~from ~~March~~June 3130, 2025, to June 30, 2027, as mutually agreed by the parties. AThe ~~copy~~Amendment ofalso ~~this~~includes ~~press~~a recital noting that on November 11, 2024, the parties mutually agreed to extend the ~~release~~Maturity isDate ~~furnished~~until asJune ~~Exhibit~~30, ~~99.1~~2025, prior to this ~~Current~~further ~~Report~~extension.The onAmendment ~~Form~~does ~~8-K~~not ~~and~~alter other material terms of the Note, including the principal amount, interest rate, or payment obligations, which remain in effect as originally stated. The full text of the Amendment is attached hereto as Exhibit 99.1 and incorporated herein by reference.

The information set forth under this Item 2.02 of this Current Report on Form 8-K (including Exhibit 99.1) is being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits – The following exhibits are filed as part of this report:

Exhibit No.		Description of Exhibit
99.1		~~Press~~Note ~~Release dated June 30, 2025.~~amendment
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Bespoke Extracts, Inc.
Date: July 7, 2025	By:	/s/ Michael Feinsod
Date: October 8, 2025	By:	/s/ Michael Feinsod
		Michael Feinsod Chief Executive Officer

Filing Compare · Bespoke Extracts, Inc.